Modified Nucleosides
Loxoribine
Quick view. Loxoribine is a 7-allyl-8-oxo guanosine derivative, CAS 121288-39-9, with beta-D-ribofuranosyl stereochemistry. CAS 121288-39-9. Catalog target purity: ≥98%. Availability: Inquiry only — contact BX Lab to confirm current availability.
Product profile
Loxoribine is classified as modified nucleosides (Formula C13H17N5O6; molecular weight 339.30).
Loxoribine is supplied for research use within the Modified Nucleosides product family.
For Loxoribine, confirm the current specification, storage conditions and downstream-method compatibility before routine use.
Names and search terms
Confirmed or normalized name variants
- 7,8-dihydro-8-oxo-7-allyl-guanosine
- 7-Allyl-8-oxoguanosine
- 7-Allyl-7,8-dihydro-8-oxoguanosine
- RWJ 21757
Useful catalog search terms
- CAS 121288-39-9
Physicochemical data
| PubChem CID | 135410906 |
|---|---|
| UNII | 9CAS0V66OI |
| InChIKey | VDCRFBBZFHHYGT-IOSLPCCCSA-N |
| SMILES | C=CCN1C2=C(NC(=NC2=O)N)N(C1=O)[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O |
| Structural state | 7-allyl-8-oxo guanosine |
| Sugar state | beta-D-ribofuranose |
| Ribose hydroxyl state | 2', 3', and 5' hydroxyl groups unprotected |
| InChI | InChI=1S/C13H17N5O6/c1-2-3-17-6-9(15-12(14)16-10(6)22)18(13(17)23)11-8(21)7(20)5(4-19)24-11/h2,5,7-8,11,19-21H,1,3-4H2,(H3,14,15,16,22)/t5-,7-,8-,11-/m1/s1 |
Release documentation
The current specification defines the analytical method and acceptance criteria; the released lot result is reported on the CoA.
Additional HPLC, MS or NMR documentation can be agreed during technical review where available.
Related products
(S)-cEt-rA
Modified Nucleosides · CAS: 1197033-34-3
BX-OP-0069S-Adenosyl-L-methionine (SAM)
Modified Nucleosides · CAS: 485-80-3
BX-MN-01875-(Carboxyhydroxymethyl)uridine
Modified Nucleosides · CAS: 934743-11-0
BX-MN-0719(R)-N6-(2,3-Dihydro-1H-inden-1-yl)adenosine
Modified Nucleosides · CAS: 96392-15-3
BX-MN-01972,2'-Cyclocytidine hydrochloride
Modified Nucleosides · CAS: 10212-25-6
BX-MN-0199N3-Allyluridine
Modified Nucleosides · CAS: 103951-13-9
Frequently asked questions
Can the package size for Loxoribine be customized?
Yes. Share the initial quantity, expected future scale, delivery timeline and packaging preference for review.
What information should be included in a quote request?
Quote catalog number BX-MN-0219 and CAS 121288-39-9, the intended research workflow, required quantity and any additional HPLC, MS or NMR documentation needed.
Product-family literature
These publications provide peer-reviewed context for the Modified Nucleosides product family and its named chemistry. They are background reading only, not evidence for the exact product, supplied form, lot specification, availability or performance.
Technology platforms
Catalog-derived platform membership for navigating related chemistry and verifiable product sets.